ISAC · International Study on Age-related disparity in Cancer patient survival
Horizon 2020 — Marie Skłodowska-Curie Actions
- Duration
- 2019-07-22 → 2021-11-10
- EU contribution
- €201,276
- Participants
- 3
- Scheme
- MSCA-IF-GF
Lines connect the coordinator with its partners.
Results in brief
International Study on Age-related disparity in Cancer patient survival
Survival in patients with cancer has considerably improved, except for older adults. The ISAC project aimed to investigate the role of comorbidities and other factors in cancer survival disparities among older patients compared with younger patients, which will aid interventions to increase the probability of survival regardless of age. Specifically, the project aimed at: 1 - Determining the contribution of comorbidities, treatment and stage at diagnosis on age-related disparities in colon and lung cancer survival in New Zealand and England; 2 - Determining the effect of social determinants notably socioeconomic position and ethnicity on age-related disparities in colon and lung cancer survival in New Zealand and England; 3 - Assessing the impact of eliminating age inequalities on colon and lung cancer survival to help inform health policymakers in England. In conclusion, age-related disparities in cancer survival are largely influenced by the stage of the disease at diagnosis and differently based on the cancer prognosis suggesting the importance of early diagnosis and individualization of cancer management in the reduction of age-related disparities in cancer survival.
Data: CORDIS, © European Union
Project objective
Cancer patients are increasingly surviving their disease, but disparities in cancer outcomes still persist, and even widen, for some groups of patients. This is the case for older adults as they have not benefitted from the improvements in cancer diagnosis and treatment at the same magnitude as their middle-aged counterparts. Older adults account for the largest proportion of cancer diagnoses, and with the number of diagnoses expected to double in two decades such disparities will result in substantial amount of years of life lost due to unfair age-related disparities in cancer survival. The ISAC project thus aims to investigate the role of comorbidities and other factors in cancer survival disparities among older patients compared with younger patients, which will aid interventions to increase the probability of survival regardless of age. Dr Sophie Pilleron will have the opportunity to be trained at the highest possible level, extending her knowledge in comorbidities and health disparities research in the University of Otago, and her knowledge in colon and lung cancer in the THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD. She will also extend her transferable skills (e.g. grant writing, oral communication, and student supervision), which are necessary for a successful career as an independent researcher. Finally, the results of the ISAC project will be disseminated and communicated to the scientific community, policy makers and the general public through a range of activities. For example, the findings of the project will be disseminated through high-impact publications and presentations at international conferences, and the Fellow will directly present her research to policy makers. She will also target non-specialists through media outlets, social networking services, online videos, or presentations at science festivals in order to facilitate the translation of the findings and their related implications to a non-scientific audience.
Original text from CORDIS.
Participants
- THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD · OxfordCoordinatorUnited Kingdom
- UNIVERSITY OF LEEDS · LeedsUnited Kingdom
- UNIVERSITY OF OTAGO · DunedinNew Zealand
Links
- View on CORDIS
- DOI: 10.3030/842817
- https://www.researchgate.net/project/International-Study-of-age-disparity-in-cancer-survival-The-ISAC-project
Data: CORDIS, © European Union